Abstract
In this study, 18 natural products were screened via anti-angiogenesis experiments, and 1 candidate product was identified, Siegesbeckiae herba, which exerted dose-dependent inhibitory effects against angiogenesis, adipogenesis, and cell adhesion. S. herba extract (SHE) exhibits an angiogenesis inhibitory effect superior to that of the EGCG from green tea leaves. The expression level of angiogenesis and adipogenesis-related signal molecules in the western blotting was reduced by increasing the amount of added SHE. Moreover, a diet supplemented with SHE was deemed more effective in inducing weight loss in LB mice than a representative synthetic diet drug, orlistat, which incidently caused the side effect of denuding the mice of their hair. These results indicate that S. herba may prove to be a useful anti-adipogenic compound, and these in vitro results may be reflected later under in vivo conditions.
Similar content being viewed by others
References
Pataky, Z., E. Bobbioni-Harsch, and A. Golay (2009) Obesity: A complex growing challenge. Exp. Clin. Endocr. Diab. 118: 427–433.
Frezza, E. E., M. S. Wachtel, and B. T. Ewing (2006) The impact of morbid obesity on the state economy: An initial evaluation. Surg. Obes. Relat. Dis. 2: 504–508.
Folkman, J. and Y. Shing (1992) Angiogenesis. J. Biol. Chem. 267: 10931–10934.
Doldi, N., M. Bassan, M. Gulisano, V. Broccoli, E. Boncinelli, and A. Ferrari (1996) Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer. Gynecol. Endocrinol. 10: 375–382.
Cao, Y. (2007) Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 117: 2362–2368.
Crandall, D. L., G. J. Hausman, and J. G. Kral (1997) A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives. Microcirculation 4: 211–232.
Hausman, G. J. and R. L. Richardson (2004) Adipose tissue angiogenesis. J. Anim. Sci. 82: 925–934.
Neels, J. G., T. Thinnes, and D. J. Loskutoff (2004) Angiogenesis in an in vivo model of adipose tissue development. FASEB J. 18: 983–985.
Voros, G., E. Maquoi, D. Demeulemeester, N. Clerx, D. Collen, and H. R. Lijnen (2005) Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinol. 146: 4545–4554.
Christiaens, V. and H. R. Lijnen (2010) Angiogenesis and development of adipose tissue. Mol. Cell Endocrinol. 318: 2–9.
Rudkowska, I., C. E. Roynette, I. Demonty, C. A. Vanstone, S. Jew, and P. J. Jones (2005) Diacylglycerol: Efficacy and mechanism of action of an anti-obesity agent. Obes. Res. 13: 1864–1876.
Obeid, O. A., S. T. Bittar, N. Hwalla, and P. W. Emery (2005) Effect of diet supplementation with glutamine, dihydroxyacetone, and leucine on food intake, weight gain, and postprandial glycogen metabolism of rats. Nutrition 21: 224–229.
Tyler, C., A. Prestwich, A. Ormond, and M. MacDougald (2007) Wnt/b-catenin signaling in adipogenesis and metabolism. Curr. Opin. Cell Biol. 19: 612–617.
Yun, J. W. (2010) Possible anti-obesity therapeutics from nature — A review. Phytochem. 71: 1625–1641.
Oh, S., K. S. Kim, Y. S. Chung, M. Shong, and S. B. Park (2009) Anti-obesity agents: A focused review on the structural classification of therapeutic entities. Curr. Top Med. Chem. 9: 466–481.
Chou, G. X., R. M. Jin, Z. T. Wang, and C. X. Chen (2006) Study on antithrombotic fraction of Herba Siegesbeckiae. Zhong Yao Cai 29: 235–237.
Hu, H. H., L. X. Tang, and X. M. Li (2004) Experimental research of effect of crude and processed Herba Siegesbeckiae on anti-inflammation and anti-rheumatism. Zhongguo Zhong Yao Za Zhi 29: 542–545.
Kim, I. Y. (1980) A study on the diuretic action of Siegesbeckiae Herba ethanol extract in dogs. J. Korean Pharm. Sci. 10: 5–13.
Lee, I., N. S. Seong, and Y. J. Lee (2005) A study on the protective effects of Siegesbeckiae Herba on neurotoxicity induced by N-methyl-D-aspartic acid (NMDA). Kor. J. Herbology 20: 121–132.
Qian, R., C. Zhang, and H. Fu (2000) Study on therapeutic mechanism of anti-rheumatism action of herba siegesbeckiae. Zhongguo Zhong Xi Yi Jie He Za Zhi 20: 192–195.
Ramírez-Zacarías, J. L., Castro-Muñozledo, F., and W. Kuri-Harcuch (1992) Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 97: 493–497.
Lee, D. H., J. P. MacIntyre, E. Wang, D. J. Hudson, A. Ishaque, J. A. Conant, B. L. Pope, and C.Y. Lau (1994) A leukocyte lipid upregulates the avidity of lymphocyte function-associated antigen-1. Biochem. Bioph. Res. Comm. 199: 319–326.
Vandermeeren, M., S. Janssens, M. Borgers, and J. Geysen (1997) Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells. Biochem. Bioph. Res. Comm. 234: 19–23.
Carmelit, P., M. G. Lampugnani, L. Moons, F. Breviaro, V. Compernolle, F. Bono, G. Balconi, R. Spagnuolo, B. Oosthuyse, M. Dewerchin, A. Zanetti, and A. Angellilo (1999) Targeted deficiency or cystolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147–157.
Zhang, D., M. Bar-Eli, S. Meloche, and P. Brodt (2004) Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: The phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J. Biol. Chem. 279: 19683–19690.
Ballinger, A. and S. R. Peikin (2002) Orlistat: Its current status as an anti-obesity drug. Eur. J. Pharmacol. 440: 109–117.
Jandacek, R. J. and S. C. Woods (2004) Pharmaceutical approaches to the treatment of obesity. Drug Discov. Today 15: 874–880.
Birari, R. B. and K. K. Bhutani (2007) Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discov. Toda. 12: 879–889.
Weigle, D. S. (2003) Pharmacological therapy of obesity: Past, present, and future. J. Clin. Endocr. Metab. 88: 2462–2469.
Choi, Y. S., H. Park, and S. Jeong (2006) Role of PI3-kinase/akt pathway in the activation of etoposide-induced NF-Kb transcription factor. J. Microbiol. Biotechn. 16: 391–398.
Tang, F. Y., N. Nhan, and M. Mohsen (2003) Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of AKT molecule. Int. J. Cancer 106: 871–878.
Tang, F. Y. and M. Meydani (2001) Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutr. Cancer 41: 119–125.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, JH., Kim, JD. Inhibitory effects of Siegesbeckiae herba extract on angiogenesis and adipogenesis. Biotechnol Bioproc E 16, 144–152 (2011). https://doi.org/10.1007/s12257-011-0012-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-011-0012-z